Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

SCPH

scPharmaceuticals

Pharmaceutical company scPharmaceuticals Inc. is making headway in the development and commercialization of a range of pharmaceutical products. Among its offerings is FUROSCIX, the company's lead p...

scPharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MNOV

MediciNova Inc.

MediciNova Inc., a California-based biopharmaceutical company, is focused on the development of innovative and small molecule therapeutics to address serious diseases with unmet medical needs in th...

MediciNova Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

MYOS

MYOS RENS Technology Inc.

MYOS RENS Technology Inc. is a New Jersey-based advanced nutrition company that focuses on developing and marketing products to improve muscle health and performance. The company's main product is ...

MYOS RENS Technology Inc. Annual Report 2018

Healthcare Drug Manufacturers - Other NASDAQ 11-50

KTOV

Kitov Pharma Ltd.

Kitov Pharma Ltd. is a clinical-stage company dedicated to developing innovative therapies to combat tumor immune evasion and drug resistance in cancer treatment. Their pipeline includes NT219, a s...

Kitov Pharma Ltd. Annual Report 2018

Healthcare Biotechnology NASDAQ 1-10

HLS

HLS Therapeutics

s. With a presence across Australia, Healius offers a range of services including medical centers, pathology labs, diagnostic imaging centers, and IVF clinics. The company has a strong focus on inn...

HLS Therapeutics Annual Report 2023

Healthcare ASX 10,000+

BYSI

BeyondSpring, Inc.

BeyondSpring Inc., a prominent biopharmaceutical company that is currently in the clinical stage, focuses on providing potential cancer therapies. The company, which comprises various subsidiaries,...

BeyondSpring, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CRIS

Curis Inc

Biotech company, Curis, Inc., is making strides in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company's clinical stage drug candid...

Curis Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

NGM

NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc. is a biopharmaceutical company with a focus on developing innovative treatments for liver and metabolic diseases, retinal diseases, and cancer. The company's pipeline i...

NGM Biopharmaceuticals, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

UCM

Uscom Limited

Uscom Limited is a global medical device company that specializes in non-invasive cardiovascular and pulmonary products. Their flagship product, USCOM 1A, is a hemodynamic monitor that measures car...

Uscom Limited Annual Report 2023

Healthcare ASX 11-50

APM

Aptorum Group Limited

Aptorum Group Limited, a biopharmaceutical company based in London, is focused on the development and commercialization of therapeutic products for the treatment of infectious diseases and cancer. ...

Aptorum Group Limited Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

ORGO

Organogenesis

Regenerative medicine company Organogenesis Holdings Inc. is making strides in the advanced wound care, surgical and sports medicine markets in the United States with its innovative product offerin...

Organogenesis Annual Report 2020

Healthcare Drug Manufacturers - Other NASDAQ 501-1000

RHT

Reliq Health Technologies

Red Hat, Inc. is a global provider of open source software solutions to businesses. They specialize in providing enterprise-ready open source operating system platforms. With their expertise in ope...

Reliq Health Technologies Annual Report 2023

Healthcare ASX 11-50

CUTR

Cutera

Cutera, Inc. is a global provider of innovative aesthetic and dermatology solutions for medical practitioners. With an emphasis on energy-based product platforms, the company boasts an impressive p...

Cutera Annual Report 2023

Healthcare Medical Appliances & Equipment NASDAQ 201-500

PLSE

Pulse Biosciences

Hayward-based Pulse Biosciences, Inc. is an innovative bioelectric medicine company that specializes in providing non-thermal treatments for a range of medical conditions. Through its groundbreakin...

Pulse Biosciences Annual Report 2023

Healthcare Medical Instruments & Supplies NASDAQ 51-200

DXB

Dimerix Limited

Australian biopharmaceutical company Dimerix Limited is currently developing DMX-200 for respiratory complications in COVID-19 patients with two ongoing Phase 3 clinical trials. The drug is also un...

Dimerix Limited Annual Report 2019

Healthcare Biotechnology ASX 1-10